Dr Ildiko Csiki | Vice President - Clinical Development
Inovio Pharmaceuticals

Dr Ildiko Csiki, Vice President - Clinical Development, Inovio Pharmaceuticals

Ildiko Csiki joined Inovio as Vice President, Clinical Development from Merck & Co. where she held the title of Senior Director, Clinical Development and was the Clinical Lead for solid tumor immuno-oncology programs. Previously she spent time at Glaxo Smith Kline as Director, Clinical Oncology in both early and late development groups. Additionally, she has been an Assistant Professor of Radiation Oncology at the University of Pennsylvania, where she has been both a clinical and laboratory Principal Investigator and a clinician with an active practice. She graduated magna cum laude from the University of Arkansas with degrees in Biology, Psychology and Chemistry and then received her MD and PhD degrees from Vanderbilt University. She also completed an internship in Internal Medicine and a Holman Research Pathway residency and fellowship in Radiation Oncology at Vanderbilt.


DC Co-conference Day 3 April 5 @ 09:10

DNA vaccines for cancer immunotherapy

  • Introduction to DNA plasmid and electroporation delivery technology
  • Updates in proof of concept studies from various trials
  • Head and neck cancer, bladder cancer, prostate cancer
  • Examples of potential combination partners
  • The regulatory landscape for DNA Vaccines

back to speakers